Category
Cancer
Sub Category
Prostate
Study Name
S1216: A Phase III Randomized Trial comparing Androgen Deprivation Therapy + Tak-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagosed Metastatic Sensitive Prostate Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance